Excess embryos from patients undergoing intracytoplasmic sperm injection and embryo transfer for male infertility were cultured to determine the rate and timing of their progression to the blastocyst stage. In 194 embryo transfer cycles, four embryos with the morphologically best grading were transferred and at least two embryos were cultured. The cycles were classified as: group 1: no excess embryos reached blastocyst stage, group 2: Ͼ50% of embryos reached blastocyst stage by days 4-5, group 3: Ͻ50% of embryos reached the blastocyst stage by days 4-5, group 4: Ͼ50% of the embryos reached blastocyst stage by days 6-7, group 5: Ͻ50% of the embryos reached blastocyst stage by days 6-7. All groups were similar regarding female age, duration of infertility, and parameters of ovarian stimulation. In group 1, clinical pregnancy and implantation rates were 14 and 11% respectively, and were similar to those of group 4. In group 2, clinical pregnancy and implantation rates were 75 and 33%. Multiple implantations occurred in 81% of group 2 or 3 cycles, compared to none in group 1 cycles. The results suggest that the development potential of the embryo is intrinsic, and that embryos which carry a high potential for development yield a high clinical pregnancy rate and multiple implantations.
Introduction
In assisted reproductive technologies, despite successful recovery and fertilization of gametes, implantation rates are relatively low following embryo transfer. This may be attributable to unfavourable in-vitro culture conditions, altered endometrial receptivity or to intrinsic characteristics (morphological or genetic) of the embryo (Hill et al., 1989) . These factors and many others which are undefined individually or collectively influence the success of implantation (Claman et al., 1987) . In-vitro fertilization (IVF) commonly results in more embryos than can be transferred. Excess embryos which cannot be cryopreserved are usually discarded or donated to research. This setting provides a unique opportunity for observing the growth potential of excess embryos kept under in-vitro culture conditions. The in-vitro growth potential of excess embryos may give insight into the behaviour of transferred sibling embryos if they are assumed to act similarly. Sjogren et al. (1992) reported a higher rate of progression to the blastocyst stage of in-vitro cultured sibling embryos from patients who became pregnant following IVF-embryo transfer. Similar observations were reported by Bordson et al. (1987) . As embryo freezing was only recently legalized in this country, we were able to observe the in-vitro behaviour of excess embryos and to correlate the growth stage reached by these embryos with the outcome of fresh embryo transfer.
Material and methods
A total of 194 couples undergoing their first cycle of ICSI for moderate to severe male factor infertility (oligoasthenoteratozoospermia) was included in the study. All females were evaluated by hysterosalpingogram or saline sonohysterography. Laparoscopy was not performed as a routine technique. ICSI was performed using spermatozoa from ejaculated semen only. The study group comprised women who had at least six fertilized oocytes.
Ovarian stimulation was performed using intranasal buserelin acetate (Suprecur; Hoechst AG, Frankfurt am Main, Germany) in a long protocol combined with follicle stimulating hormone/human menopausal gonadotrophin (FSH/HMG) (Metrodin 75, I.F.; Pergonal 500, I.F. Serono, Rome, Italy). Oocyte retrieval with transabdominal ultrasound guidance was performed 36 h after the injection of 10 000 IU of human chorionic gonadotrophin (HCG) (Profasi HP 5000, I.F. Serono). Following ICSI, the oocytes were cultured in IVF-50 medium (Scandinavian IVF Science AB, Gotenborg, Sweden). The four embryos with the morphologically best grading were transferred transcervically into the uterus using the Wallace catheter (Edwards-Wallace Embryo Replacement Catheter; Simcare, West Sussex, UK) for easy cases and the Frydman catheter (Set de Frydman Pour Transfert Difficile; Laboratoire C.C.D., Paris, France) for difficult cases. Transfers were performed 48 h after oocyte retrieval. All women received 200 mg doxycycline (Monodoks; DEVA, Istanbul, Turkey) and 16 mg methylprednisolone (Prednol; Mustafa Nevzat, Ilac Sanaji, Istanbul, Turkey) daily for 5 days starting on the day of oocyte retrieval. The luteal phase was supplemented with intravaginal micronized progesterone (Utrogestan, Laboratories Besins Iscovesco, Paris, France) at a dose of 600 mg daily in three divided doses starting on the day of oocyte retrieval. Pregnancy was defined by appropriate doubling of β-HCG concentrations assessed 12 and 14 days after embryo transfer. Clinical pregnancy was defined as the presence of gestational sac/s on vaginal ultrasonography performed 4 weeks after embryo transfer. Implantation rate was defined as the number of ultrasonically defined gestational sacs divided by the number of embryos transferred.
Excess embryos were transferred to fresh culture medium every 24 h. IVF-50 was used until the 6-8 cell stage, 50% IVF-50 and 50% Hatch 50 (Scandinavian IVF Science AB) from the eight cell to the 14-16 cell stage and Hatch-50 until the blastocyst stage. Informed consent was obtained from all patients. The patients were advised that embryo manipulation would not be performed at any time during the observation period. The study was approved by the ethics committee of the American Hospital of Istanbul. The outcome of embryo transfer was analysed according to the stage of embryonic development reached by the excess embryos. Statistical analysis was performed using one-way analysis of variance and Tukey post-hoc test. Significance was accepted at P Ͻ 0.05.
Results
The couples were classified as follows: group 1: none of the excess embryos reached the blastocyst stage, group 2: Ͼ50% of the embryos reached the blastocyst stage by day 4-5, group 3: Ͻ50% of the embryos reached the blastocyst stage by days 4-5, group 4: Ͼ50% of the embryos reached the blastocyst stage by days 6-7, group 5: Ͻ50% of the embryos reached the blastocyst stage by days 6-7.
There was no difference between the groups in semen parameters, including sperm concentration, motility or morphology. The groups did not differ regarding parameters including mean female age, duration of infertility, duration of ovarian stimulation, serum oestradiol and progesterone concentrations on the day of HCG, mean number of oocytes retrieved, mean number of G1 (even blastomeres and no fragmentation) and G2 (even blastomeres and Ͻ20% fragmentation) embryos transferred, and the transfer score (Table I) . Transfer score was calculated according to Puissant et al. (1987) .
The number of cycles with a positive β-HCG test and the clinical pregnancy and implantation rates per embryo in different groups are shown in Table II . When none of the excess embryos reached the blastocyst stage (group 1) clinical pregnancy and implantation rates were 14 and 11% respectively. When Ͼ50% of the excess embryos reached the blastocyst stage on days 4-5 (group 2), clinical pregnancy and implantation rates were 75 and 33%. When the blastocyst stage was reached on days 6-7 by Ͻ50% of the embryos under observation (group 4), the clinical pregnancy and implantation rates were similar to the cycles where none of the embryos reached the blastocyst stage.
Multiple pregnancy rate was extremely high when Ͼ50% 2565 of sibling embryos reached the blastocyst stage on days 4-5 (Table II) . In this group, double and triple implantations were observed in respectively 58 and 23% of the cycles. Multiple implantations were also very common in groups 3 and 4.
Discussion
Until recently, embryo cryopreservation was not legally permitted in this country. Therefore, excess embryos were discarded, although some of the couples wished to preserve them for later use. This setting gave us the chance to observe the behaviour of excess embryos under in-vitro culture conditions using simple media and to correlate the behaviour of these excess embryos with the clinical outcome after embryo transfer. We included only cycles of intracytoplasmic sperm injection (ICSI) performed for varying degrees of sperm defects. Currently in our programme~80% of all assisted reproductive technology cycles are ICSI procedures performed for male factor infertility. For the sake of homogeneity and due their small number, we excluded IVF-embryo transfer cycles. In all the cycles studied, at least four embryos were available for transfer and at least two other embryos for observation under in-vitro culture. Buster et al. (1985) showed that among 86 embryos recovered by uterine flushing 5 days after intrauterine insemination performed in a natural or stimulated cycle, 42% were at the blastocyst stage indicating normal development. Intrauterine transfer of these embryos in an embryo donation programme proved that the blastocysts resulted in the highest implantation rate per transfer (59%) when compared with morulae or early embryonic stages. We therefore selected day 4-5 expanded blastocysts as representing embryos at their optimal developmental stage for implantation. The results of our study suggest that when excess embryos observed under in-vitro culture conditions reach the expanded blastocyst stage on days 4-5, the implantation rate of the transferred sibling embryos is high, and is associated with high multiple pregnancies. When no embryos reach the expanded blastocyst stage or Ͻ50% of the excess embryos reached the blastocyst stage by days 6-7 (late cleavage), corresponding implantation and pregnancy rates were much lower. Thus high implantation rates after blastocyst transfer may be due to good embryo developmental potential rather than to the fact that the embryos were transferred at the blastocyst stage. Sjogren et al. (1992) cultured spare human pre-embryos and compared the pregnancy rate with blastocyst formation in vitro. In the group of patients in whom pregnancy occurred, at least one of the spare preembryos developed to the blastocyst stage. In patients who did not become pregnant, the corresponding rate was 53% (Sjogren et al., 1992) . The authors suggested that if one embryo has a high potential for development, there is an increased probability that other embryos originating from the same cycle will also develop to advanced stages. It is now widely accepted that human embryos resulting from IVF have different developmental capacities related to their intrinsic quality (Plachot, 1992) . Embryos at an appropriate developmental stage have a higher chance of implanting into a receptive uterus. Our findings suggest that it is the quality of the embryo itself that determines implantation. Noninvasive assessment of embryo quality and viability is a crude science at present. Although it is common to classify embryos according to their morphological features and transfer those that appear best, unless there is gross fragmentation, there is little difference in pregnancy rates for various grades of embryos (Claman et al., 1987) . Recently, Shoukir et al. (1997) analysed the relationship between early embryo cleavage and increased pregnancy rates following their transfer. An embryo which cleaves earlier than its siblings may be more viable and possess a greater potential to implant into a receptive uterus. Whether there is a relationship between early cleavage and progression to later stages of embryo development, however, has to be evaluated. In our study we did not assess early cleavage, and therefore cannot comment on the above assumption. The role of the endometrium and the importance of endometrial receptivity may be less important than previously thought and may be facilitatory rather than permissive. However, cycles giving rise to embryos that have a higher developmental capacity may also result in an endometrium that is more receptive to implantation. These interrelated factors may 2566 be also affected by the hormonal milieu induced by ovarian stimulation.
Embryos graded as morphologically better and those that develop into blastocysts may have a better metabolic and genetic capacity to implant. Despite the fact that the groups had similar numbers of GI-II embryos available for transfer and similar embryo scores, pregnancy rates were different. These differences may have been due to different developmental capacities as indicated from the culture of the excess embryos. We suggest that the behaviour of the transferred embryos in the uterus and that of their sibling counterparts in vitro may be similar. Our findings also suggest that all the embryos in a cohort from the same patient behave similarly in culture and the uterus. Therefore the transfer of a large number of embryos with a good developmental capacity will lead to unacceptably high multiple pregnancy rates. In view of these findings, the transfer of blastocysts appears to be extremely important in enabling the selection of those embryos with the highest potential to implant and thus limiting the possibility of multiple implantations (Plachot et al., 1991) . Olivennes et al. (1994) reported that the transfer of blastocysts was beneficial in women with previous repeated failure of implantation, and for patients in whom multiple pregnancies had to be avoided. Furthermore, embryo transfer at the blastocyst stage allowed embryo assessment in vitro and also appeared to yield higher implantation rates after cryopreservation and thawing. The latter view was supported by Kaufman et al. (1995) , who reported an implantation rate of 13.4% per frozen thawed blastocyst. In this respect, our study supports the commonly shared view that blastocyst stage transfer of a maximum of two embryos avoids high rank multiple pregnancies and optimizes pregnancy rates. Although earlier attempts to prolong in-vitro culture to the blastocyst stage resulted in limited success (Bolton et al., 1989) , embryo culture in better defined simple media will inevitably obviate the use of feeder cells, making the procedure more efficient, available and easier to perform. In a recent study, Jones et al. (1998) found that 52% of zygotes progressed to the blastocyst stage in an optimized culture protocol which consisted of simple media.
Regulators of early embryonic development such as amino acids and/or vitamins, when added to simple culture media, result in high rates of blastocyst development (Gardner and Lane, 1997) . Undoubtedly, blastocyst transfer will gain more acceptance if a high percentage of in-vitro cultured embryos reach that stage. The key to this appears to lie with the optimization of culture media supporting embryo metabolism in vitro. In accordance with the above findings, in a recent study Jones et al. (1998) showed that 52% of zygotes progressed to the blastocyst stage using an optimized culture protocol consisting of simple media.
In conclusion, our results suggest that the zygote may be endowed with an inherent capacity to progress to later stages of embryonic development and that this capacity may be reflected in the sibling oocytes undergoing in-vitro culture. Patients whose embryos have the potential to develop to the blastocyst stage may attain very high pregnancy rates, possibly including unacceptable multiple pregnancies. Our results strongly support blastocyst transfer to optimize the results of assisted conception.
